RxDoctor Payments Data

Ashley Siemonh

Women's Health · Waldorf, MDNPI 1740842475

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $902 of the $1,152 with a category attached, or 78.3%. It is spread thinly across 10 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $516, 7.1 times the $73 reported in 2022.

$1,152in general payments, 2019–2025

Across 31 payments — averaging $37.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hologic Sales And Service, LLC$257
  • Shield Therapeutics Inc$250
  • Astellas Pharma US Inc$166
  • Sumitomo Pharma America, Inc.$155
  • Organon$106
  • Pfizer$66
  • plus $152 from 4 others

What the payments were for

  • Speaking & faculty fees$25022%
  • Food & beverage$90278%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,152 in reported general payments places this provider in the 80th percentile of 95 women's health providers in Maryland.

See all women's health providers in Maryland

Medicare billing

Part B allowed, 2024
$6,603
Medicare patients
58
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol (Twice Weekly)Estradiol12$1,076
Estradiol14$836
Metronidazole15$153
Fluconazole12$49

Paid to pharmacies, not to this prescriber.

Other women's health in Waldorf

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →